06:25:51 EDT Mon 15 Aug 2022
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save
Avicanna Inc
Symbol AVCN
Shares Issued 41,271,574
Close 2021-06-11 C$ 1.08
Recent Sedar Documents

Avicanna begins Rho Phyto, Pura Earth sales in Alberta

2021-08-24 10:05 ET - News Release

Mr. Aras Azadian reports

AVICANNA EXPANDS SALES OF PURA EARTH AND RHO PHYTO BRANDED TOPICALS INTO ALBERTA'S RETAIL CHANNELS

Avicanna Inc.'s Rho Phyto and Pura Earth branded topicals have attained initial listings and commenced sales in the Canadian province of Alberta.

As part of the development process, Avicanna's topicals have gone through various preclinical and clinical evaluation before being released to the market. These complex and proprietary topical products are developed through Avicanna's renowned R&D (research and development) platform and formulated to deliver cannabinoids with synergistic natural active ingredients with long-term shelf-life stability, consistency and enhanced absorption. Avicanna's topical formulations are developed starting with the cannabinoids in the oil phase -- a process that is critical in preventing degradation, ensuring homogeneity and increasing absorption of cannabinoids into the skin. Avicanna's research team brings years of product development and topical formulation expertise and has developed dozens of SKUs (stock-keeping units) of cosmetics, medical and pharmaceutical preparations that available in several countries.

Aras Azadian, Avicanna's chief executive officer, commented: "We are thrilled to enter another major Canadian province with several of our proprietary products and two of our brands. With the emergence of cannabis 2.0 products, the market has been saturated with low-quality products such as topicals, which are often produced by infusing cannabis extract into a preformulated based cream. This has been to the detriment of emerging wellness segment within the Canadian cannabis industry and a source of disappointment to the consumers who have high expectations for such products. Our market approach is to deliver these proprietary products with the support of appropriate education and training to all stakeholders. This approach will be a driving force in the establishment and growth of the wellness category and market for functional cannabinoid-based products."

Pura Earth products overview

An advanced and clinically tested line of CBD (cannabidiol) consumer derma-cosmetic products, these unique formulations are THC-free (tetrahydrocannabinol), dermatologist tested for irritation, cruelty-free and vegan. The fast-absorbing formulas combine pure CBD with natural ingredients, providing functional benefits for specific needs. Pura Earth products fit into any daily self-care routine and can be used in conjunction with other skin care products.

Rho Phyto extra-strength deep tissue gel overview

The gel is part of the most complete and advanced medical cannabis formulary, including oral, sublingual and topical products, with proven success in the medical channels across Canada, including Medical Cannabis by Shoppers, and the first formulary to be available in a major Canadian hospital, Sunnybrook Health Sciences Center in Toronto.

The advanced emulsion formula has proven deep tissue delivery and increased absorption into deeper layers of the skin. The fast-absorbing, water-based formula synergistically combines cannabinoids and functional natural terpenes, including menthol and clove oil, which contains eugenol and beta-caryophyllene. This formulation is currently in continuing preclinical studies evaluating the efficacy of the deep tissue gel for attenuating pain and inflammation in osteoarthritis. In addition, the gel is enrolled in the observational medical cannabis real-world evidence study for patients with chronic pain conducted by the University Health Network.

About Avicanna Inc.

Avicanna is a diversified and vertically integrated Canadian biopharmaceutical company focused on the research, development and commercialization of plant-derived, cannabinoid-based products for the global consumer, medical and pharmaceutical market segments.

Avicanna is an established leader in cannabinoid research and development, which it primarily conducts at its R&D (research and development) headquarters in the Johnson & Johnson innovation centre JLABS @ Toronto, Canada, and in collaboration with leading Canadian academic and medical institutions. In addition to its developing pharmaceutical pipeline, Avicanna's team of experts has developed and commercialized several industry-leading product lines, including:

  • Pura Earth or Pura H&W -- an advanced and clinically tested line of CBD consumer derma-cosmetic products;
  • Rho Phyto -- an advanced line of medical cannabis products containing varying ratios of CBD and THC currently available nationwide across Canada in partnership with Medical Cannabis by Shoppers; Rho Phyto is the first strictly medical formulary of advanced cannabis 2.0 products, containing oils, sprays, capsules, creams and gels, all developed with scientific rigour, manufactured under GMP (good manufacturing practice) standards and supported by preclinical data.

With continuing clinical trials on its derma-cosmetic (branded as Pura Earth or Pura H&W) products, medical cannabis products (branded as Rho Phyto) and a pipeline of pharmaceutical products, Avicanna's dedication to researching the important role that cannabinoids play in an increasingly wider scope of products has been at the core of the company's vision since its inception. Furthermore, Avicanna's commitment to education is demonstrated through its annual medical symposium, the Avicanna Academy educational platform and the My Cannabis Clinic patient program through its subsidiary company.

Avicanna manages its own supply chain, including cultivation and extraction through its two majority-owned subsidiaries, Sativa Nativa SAS and Santa Marta Golden Hemp SAS, both located in Santa Marta, Colombia. Through these sustainable, economical and industrial-scale subsidiaries, Avicanna cultivates, processes and commercializes a range of cannabis and hemp cultivars dominant in CBD, CBG (cannabigerol), THC and other cannabinoids for use as active pharmaceutical ingredients. Avicanna's Avesta Genetica program specializes in the development and optimization of rare cultivars for commercial production along with feminized seeds for global export. In June, 2020, Avicanna made history with a shipment of hemp seeds to the United States by completing the first-ever export of hemp seeds from Colombia.

We seek Safe Harbor.

© 2022 Canjex Publishing Ltd. All rights reserved.